Product Information
METHYLPREDNISOLONE 16 MG TAB is a generic product labeled by Chartwell RX LLC, priced at $1.4461 per EA under NDC 62135076250. Its NADAC has been published 56 times since Sep 10, 2025.
FDA first approved this application on Feb 22, 2019.
Strength
16 mg/1
Manufacturer
Chartwell RX LLCNDC
62135076250
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPREDNISOLONEApproval Type
Generic (ANDA)
FDA Application
ANDA209097FDA Approved
2/22/2019
On Market Since
2/22/2019
Pharmacological Classes
Price Statistics
The NADAC for METHYLPREDNISOLONE 16 MG TAB has been published 56 times since Sep 10, 2025, and over the history we have for it it has declined 7.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4461 per EA |
|---|---|
| All-time high | $1.6239 (Oct 15, 2025) |
| All-time low | $1.3724 (Jun 17, 2026) |
| 52-week high | $1.6239 |
| 52-week low | $1.3724 |
| Median price | $1.4461 |
| Average price | $1.4780 |
| Largest weekly change | -4.3% (Mar 18, 2026) |
| Weeks tracked | 56 |
| Tracking since | Sep 10, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Methylprednisolone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methylprednisolone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPREDNISOLONE 16 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPREDNISOLONE 16 MG TAB, manufactured by Chartwell RX LLC, is $1.4461 per EA (NDC 62135076250), effective Sep 30, 2026.
How has the price of METHYLPREDNISOLONE 16 MG TAB changed over time?
Over the history we have for it, the NADAC for METHYLPREDNISOLONE 16 MG TAB has declined 7.5%. It has been tracked across 56 weekly CMS publications since Sep 10, 2025.
What are the highest and lowest recorded NADAC prices for METHYLPREDNISOLONE 16 MG TAB?
Since Sep 10, 2025, the NADAC for METHYLPREDNISOLONE 16 MG TAB has ranged from a low of $1.3724 (Jun 17, 2026) to a high of $1.6239 (Oct 15, 2025), with a median of $1.4461 per EA.
Are there cheaper alternatives to METHYLPREDNISOLONE 16 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of METHYLPREDNISOLONE 16 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METHYLPREDNISOLONE 16 MG TAB?
METHYLPREDNISOLONE 16 MG TAB (NDC 62135076250) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.